| Document Date: 2015-05-18 06:39:50
Open Document File Size: 599,70 KBShare Result on Facebook
City Helsinki / / Company Transplantation Laboratory / SPECT/CT / Finland 3 Laboratory / Finland 2TILT Biotherapeutics Ltd / / Facility University of Helsinki / Laboratory of Radiochemistry / Haartman Institute / / IndustryTerm in vivo imaging / treatment of cancer / / MedicalCondition tumor / Virustreated tumors / significant tumor / cancer / tumors / OVA tumor / OVA mouse melanoma / Relative tumor / OVA murine melanoma tumors / solid tumors / established tumor / / MedicalTreatment Gene Therapy / Adoptive transfer / Oncolytic virotherapy / cell therapy / / Organization Department of Pathology and Transplantation Laboratory / University of Helsinki / Haartman Institute / Department of Chemistry / / Person Ad Ad / Markus Vähä-Koskela / / Position mouse melanoma model / / Product Adenovirus injections / / Technology Gene Therapy / cell therapy / /
SocialTag |
Oncolytic adenovirus improves anti-tumor efficacy of adoptive T-cell therapy by breaking tumor tolerance Siri Tähtinen1, Susanna Grönberg-Vähä-Koskela1, Dave Lumen3, Maiju Merisalo-Soikkeli1, Mikko Siurala1,2, Anu J.